Press Release – New York, NY – September 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and …
Sichenzia Ross Ference Carmel LLP Represents Bancroft Capital, LLC in $9.5 Million Initial Public Offering of Ordinary Shares of Premium Catering (Holdings) Limited
Press Release – New York, NY –September 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Bancroft Capital, LLC in a $9.5 million initial public offering of ordinary …
Sichenzia Ross Ference Carmel LLP represents INmune Bio Inc. in $13.0 Million Registered Direct Offering
Press Release – New York, NY – September 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio (Nasdaq: INMB), a clinical-stage inflammation and immunology …
Sichenzia Ross Ference Carmel LLP 代表 Sharps Technology, Inc. 完成 350 万美元过桥融资
新闻稿 – 纽约州纽约 – 2024 年 9 月 24 日 – Sichenzia Ross Ference Carmel LLP 今天宣布，它代表 Sharps Technology, Inc.（纳斯达克股票代码：STSS），这是一家创新型医疗器械和药品包装公司，提供一流的专利技术注射器产品，在其先前宣布的约 350 万美元的过桥融资结束时。 Aegis Capital …
Continue Reading about Sichenzia Ross Ference Carmel LLP 代表 Sharps Technology, Inc. 完成 350 万美元过桥融资 →
Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $3.5 Million Bridge Financing
Press Release – New York, NY – September 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and …
Sichenzia Ross Ference Carmel LLP Represents Elevai Labs, Inc. in Pricing of $8.0 Million Public Offering
New York, NY - September 24, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Elevai Labs, Inc. ("Elevai" or the "Company"), a pioneering force in medical aesthetics, in the …
